H1B Report
Side-by-side comparison

AnMed Health vs COGNIZANT TECHNOLOGY SOLUTIONS US CORP

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
AnMed Health
SCRank #FEIN 57-0359174
Entity B
COGNIZANT TECHNOLOGY SOLUTIONS US CORP
TXRank #2FEIN 13-3924155

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricAnMed HealthCOGNIZANT TECHNOLOGY SOLUTIONS US CORP
Total filings36128,852
Certified %86.11%96.13%
Denied %5.56%0.28%
Withdrawn %2.78%2.23%
Cert-withdrawn %5.56%1.36%
Rank#2
Active yearsFY2011–FY2026FY2010–FY2026
Worksite stateSCTX

Outcomes — AnMed Health

DOL case-status mix.

Outcome breakdown: Certified 86.1%, Cert-withdrawn 5.6%, Withdrawn 2.8%, Denied 5.6%
Outcome breakdown
OutcomeShare
Certified86.1%
Cert-withdrawn5.6%
Withdrawn2.8%
Denied5.6%
Certified86.1%
Cert-withdrawn5.6%
Withdrawn2.8%
Denied5.6%

Outcomes — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

DOL case-status mix.

Outcome breakdown: Certified 96.1%, Cert-withdrawn 1.4%, Withdrawn 2.2%, Denied 0.3%
Outcome breakdown
OutcomeShare
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.2%
Denied0.3%
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.2%
Denied0.3%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

AnMed Health
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY20113
FY20122
FY20134
FY20144
FY20151
FY20163
FY20174
FY20183
FY20192
FY20200
FY20210
FY20220
FY20230
FY20243
FY20255
FY20262
COGNIZANT TECHNOLOGY SOLUTIONS US CORP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20101,476
FY20112,735
FY20121,772
FY20131,557
FY20142,189
FY20153,112
FY20164,612
FY20172,384
FY201812,460
FY201925,569
FY20203,117
FY202110,079
FY202213,705
FY202315,729
FY202411,437
FY202511,140
FY20265,779

Top 5 occupations — AnMed Health

Top 5 occupations — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.